Possible participation of intracellular platelet-activating factor in NF-κB activation in rat peritoneal macrophages

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1583, Issue 1, 2002, Pages 26-34

  Tsuyuki, Kousei ^a   Ichinowatari, Gaku ^a   Tanimoto, Atsuo ^a   Yamada, Masateru ^a   Yaginuma, Hiroshi ^a   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Intracellular platelet activating factor (PAF); Lipopolysaccharide (LPS); Macrophage; NF B; PAF antagonist; Thapsigargin

Indexed keywords

1 ETHYL 2 [N (2 METHOXYBENZOYL) N [2 METHOXY 3 [4 (OCTADECYLCARBAMOYLOXY)PIPERIDINOCARBONYLOXY]PROPOXYCARBONYL]AMINOMETHYL]PYRIDIN IUM CHLORIDE; 1 ETHYL 2 [N (2 METHOXYBENZOYL) N [2 METHOXY 3 [4 (OCTADECYLCARBAMOYLOXY)PIPERIDINOCARBONYLOXY]PROPOXYCARBONYL]AMINOMETHYL]PYRIDINIUM CHLORIDE; 2,5 BIS(3,4,5 TRIMETHOXYPHENYL)TETRAHYDROFURAN; 6 (2 CHLOROPHENYL) 9 CYCLOPROPYLCARBONYL 7,8,9,10 TETRAHYDRO 1,4 DIMETHYL 4H PYRIDO[4',3':4,5]THIENO[3,2 F][1,2,4]TRIAZOLO[4,3 A][1,4]DIAZEPINE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ENZYME INHIBITOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; SK F 98625; THAPSIGARGIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG DEGRADATION; DRUG EFFECT; MALE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; AZEPINES; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; HYDROLYSIS; IMIDAZOLES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORYLATION; PIPERIDINES; PLATELET ACTIVATING FACTOR; PYRIDINIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; THAPSIGARGIN; TRIAZOLES;

EID: 0037071833     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(02)00161-0     Document Type: Article

References (51)

1. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
2. An inducible transcription factor activates expression of human immunodeficiency virus in T cells
3. Lipopolysaccharide stimulates both nuclear localization of the nuclear factor κB 50-kDa subunit and loss of the 105-kDa precursor in RAW264 macrophage-like cells
4. The NF-κB and IκB proteins: New discoveries and insights
5. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
6. Involvement of a NF-κB-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines
7. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages
8. Regulation of the IL-2 receptor α-gene. Interaction of a κB binding protein with cell-specific transcription factors
9. Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines
10. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene
11. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1
12. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter
13. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB
14. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB
15. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
16. Mechanisms by which IκB proteins control NF-κB activity
17. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
18. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation
19. Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor
20. The influence of phosphorylation state ratio on energy conservation in mitochondria treated with inorganic arsenate
21. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
22. Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation
23. Platelet-activating factor and macrophages: I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes
24. The release of a platelet-activating factor by stimulated rabbit neutrophils
25. Biosynthesis of platelet-activating factor and enzyme inhibitors
26. Effects of CoA-independent transacylase inhibitors on the production of lipid inflammatory mediators
27. Platelet-activating factor triggers the phosphorylation and activation of MAP-2 kinase and S6 peptide kinase activity in human B cell lines
28. Transfected platelet-activating factor receptor activates mitogen-activated protein (MAP) kinase and MAP kinase kinase in Chinese hamster ovary cells
29. Inositol phospholipids-specific phospholipase C: Interaction of the gamma 1 isoform with tyrosine kinase
30. Regulation of stably transfected platelet activating factor receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation
31. Protein kinase C δ specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation
32. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites
33. Thapsigargin and thapsigargicin, two histamine liberating sesquiterpene lactones from Thapsia garganica. X-ray analysis of the 7,11-epoxide of thapsigargin
34. Absolute configurations of the histamine liberating sesquiterpene lactones thapsigargin trilobolide
35. Enhancement by cyclo-oxygenase inhibitors of platelet-activating factor production in thapsigargin-stimulated macrophages
36. Preparation of Immunoaffinity mini-columns for the analysis of platelet activating factor (PAF) in biological samples
37. Inhibition of tumor necrosis factor-α production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages
38. 2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide
39. Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses
40. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3- (4-octadecylcarbamoyloxy)piperidinocarbonyl-oxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models
41. Trans-2,5-Bis-(3,4,5-trimethoxyphenyl) tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor
42. Activation of the transcription factor NF-κB in human tracheobronchial epithelial cells by inflammatory stimuli
43. Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased κB binding activity
44. 2+-dependent route of priming in the production of lipid mediators by human polymorphonuclear leukocytes
45. 2+ transport ATPase mediate resistance to thapsigargin in thapsigargin-resistant hamster cells
46. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin
47. Toll-like receptors in the induction of the innate immune response
48. A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
49. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
50. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κ B abrogates established experimental colitis in mice
51. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production